Herzich Paul
SEC CIK 1954991 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | CTO | 72.6K | — | $308.5K | 13 | 2023-12-02 | 2026-02-18 |
Most active insiders at SLDB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cumbo Alexander | Pres, CEO, Dir | — | $984.0K |
| 2 | Howton David T | COO | — | $433.6K |
| 3 | Tan Kevin | CFO, Treas | — | $329.5K |
| 4 | Hanrahan Jessie | Chief Regulatory Off | — | $297.4K |
| 5 | Brooks Gabriel | Chief Medical Off | — | $281.0K |
| 6 | Herzich Paul | CTO | — | $274.1K |
| 7 | Ganot Ilan | Dir | — | $82.4K |
| 8 | SMITH IAN F | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-02-18 | 2026-02-13 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | M - OptEx | — | +7,187 | 76.3K | +10% | — |
| DT | 2026-02-18 | 2026-02-18 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale+OE | $5.82 | -3,616 | 72.6K | -5% | -$21.0K |
| T | 2026-02-06 | 2026-02-04 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale | $6.44 | -10.9K | 69.1K | -14% | -$70.2K |
| DMT | 2026-02-02 | 2026-01-29+ | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | M - OptEx | — | +79.6K | 81.5K | +4,088% | — |
| DT | 2026-02-02 | 2026-02-02 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale+OE | $6.44 | -26.2K | 80.0K | -25% | -$169.1K |
| DT | 2025-12-04 | 2025-12-02 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | M - OptEx | — | +7,239 | 29.3K | +33% | — |
| DT | 2025-12-04 | 2025-12-03 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale+OE | $5.11 | -2,701 | 26.6K | -9% | -$13.8K |
| DT | 2025-02-18 | 2025-02-13 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | M - OptEx | — | +7,187 | 21.1K | +52% | — |
| DT | 2025-02-18 | 2025-02-14 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale+OE | $3.96 | -2,688 | 18.4K | -13% | -$10.6K |
| D | 2024-12-04 | 2024-12-03 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale+OE | $5.60 | -2,777 | 12.2K | -19% | -$15.6K |
| D | 2024-12-04 | 2024-12-02 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | M - OptEx | — | +7,239 | 15.0K | +94% | — |
| D | 2023-12-05 | 2023-12-02 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | M - OptEx | — | +7,238 | 7,238 | New | — |
| D | 2023-12-05 | 2023-12-04 | SLDB | Solid Biosciences Inc. | Herzich Paul | CTO | S - Sale+OE | $2.77 | -2,968 | 4,270 | -41% | -$8,221 |
Purchase Sale Sale after option exercise All abbreviations